NCT00268255
|
|
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
|
Phase 1/Phase 2
|
Withdrawn
|
NCT00227773
|
|
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
|
Phase 2
|
Withdrawn
|
NCT02321293
|
2015-02-01 |
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
|
Phase 1
|
Not Yet Recruiting
|
NCT02259049
|
2014-10-01 |
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
|
Phase 0
|
Recruiting
|
NCT02035501
|
2014-01-01 |
Treatment of TNNT1-Myopathy With L-Tyrosine.
|
Phase 2
|
Enrolling By Invitation
|
NCT01998061
|
2013-12-01 |
Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression
|
Phase 2
|
Recruiting
|
NCT01676103
|
2012-09-01 |
The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease
|
Phase 1/Phase 2
|
Completed
|
NCT01460498
|
2012-08-01 |
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT01259544
|
2009-01-01 |
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
|
Phase 2
|
Completed
|
NCT00390364
|
2006-10-01 |
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
|
Phase 2
|
Terminated
|
NCT00258297
|
2004-04-01 |
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
|
Phase 2
|
Terminated
|
NCT00204295
|
2004-01-01 |
Study on Amino Acid Uptake in Brain Tumors
|
Phase 2
|
Active, Not Recruiting
|
NCT00047788
|
2002-10-01 |
Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
|
Phase 2
|
Completed
|
NCT00302289
|
2000-01-01 |
B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients
|
Phase 1
|
Completed
|
NCT00000322
|
1997-04-01 |
Tyrosine for Methamphetamine Dependence - 1
|
Phase 2
|
Completed
|